help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SLEBOS, D.-J.
Right arrow Articles by KAUFFMAN, H. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SLEBOS, D.-J.
Right arrow Articles by KAUFFMAN, H. F.

Am. J. Respir. Crit. Care Med., Volume 165, Number 4, February 2002, 501-507

Longitudinal Profile of Bronchoalveolar Lavage Cell Characteristics in Patients with a Good Outcome after Lung Transplantation

DIRK-JAN SLEBOS, JANNY SCHOLMA, H. MARIKE BOEZEN, GERARD H. KOËTER, WIM VAN DER BIJ, DIRKJE S. POSTMA, and HENK F. KAUFFMAN

Department of Pulmonary Diseases and Lung Transplantation and Department of Allergy, University Hospital; and Department of Epidemiology, University of Groningen, Groningen, The Netherlands

Bronchoalveolar lavage fluid (BALF) analysis is used in patients after lung transplantation (LTX) to obtain more insight into pathological conditions such as acute and chronic allograft rejection. Information on the normal course of BALF cell characteristics in patients with "good outcome" after LTX is limited. Therefore we analyzed 169 BALF samples from 63 well-defined "good outcome" patients after LTX (no acute or chronic transplant dysfunction, bacterial, fungal, or viral infections at the time of BAL). Total cell count decreased from the first months: median (range) 234 × 103 (70-610) cells/ml to 103 × 103 (10-840) cells/ml during the second year posttransplantation (p < 0.001). Cell differential counts did not change during the 2-yr study period. The CD4/CD8 ratio increased significantly from 0.32 (0.11-0.46) just posttransplantation to 0.62 (0.16-4.27) the second year after LTX. This increasing ratio was mainly due to a sharp decreasing CD8+ cell count. Thus, characteristics of BAL cellular patterns in patients with good outcomes after LTX show important changes over time. We have defined control values for the BALF cellular profile in patients without pathological airway conditions after LTX. We propose to use these control values as a tool for diagnosing patients with pulmonary complications after LTX and for the follow-up of treatment regimens.




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
I. Al-Githmi, N. Batawil, N. Shigemura, M. Hsin, T. W. lee, G.-W. He, and A. Yim
Bronchiolitis obliterans following lung transplantation
Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 846 - 851.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Boehler and M. Estenne
Post-transplant bronchiolitis obliterans
Eur. Respir. J., December 1, 2003; 22(6): 1007 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Estenne and M. I. Hertz
Bronchiolitis Obliterans after Human Lung Transplantation
Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 440 - 444.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society 		  CCM abstracts